论文信息 - Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study. - 字舞流文

Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.

C. Verstuyft | P. Scarabin | A. Guiochon‐Mantel | L. Carcaillon | M. Canonico | E. Bouaziz | Frédéric Martin

[1] F. Drobniewski,et al. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women : systematic review and meta-analysis , 2008 .

[2] E. Oger,et al. Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study , 2007, Circulation.

[3] A. deFazio,et al. Overlapping and distinct expression of progesterone receptors A and B in mouse uterus and mammary gland during the estrous cycle. , 2006, Endocrinology.

[4] G. Colditz,et al. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5] E. Milgrom,et al. Progesterone receptor expression in human saphenous veins. , 1995, Circulation.